SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-19-007384
Filing Date
2019-11-08
Accepted
2019-11-08 16:45:23
Documents
54
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_110819p.htm 10-Q 634293
2 EXHIBIT 10.1 exh_101.htm EX-10.1 49469
3 EXHIBIT 10.2 exh_102.htm EX-10.2 50529
4 EXHIBIT 31.1 exh_311.htm EX-31.1 8569
5 EXHIBIT 31.2 exh_312.htm EX-31.2 8804
6 EXHIBIT 32.1 exh_321.htm EX-32.1 3872
7 EXHIBIT 32.2 exh_322.htm EX-32.2 3673
  Complete submission text file 0001171843-19-007384.txt   4453997

Data Files

Seq Description Document Type Size
8 XBRL PRESENTATION FILE bcrx-20190930_pre.xml EX-101.PRE 396406
9 XBRL LABEL FILE bcrx-20190930_lab.xml EX-101.LAB 348232
10 XBRL DEFINITION FILE bcrx-20190930_def.xml EX-101.DEF 385830
11 XBRL CALCULATION FILE bcrx-20190930_cal.xml EX-101.CAL 37387
12 XBRL SCHEMA FILE bcrx-20190930.xsd EX-101.SCH 52060
13 XBRL INSTANCE FILE bcrx-20190930.xml EX-101.INS 816948
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 191204635
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences